You are viewing: Rest Of Asia Pacific Endoscopic Submucosal Dissection/ESD Market analysis

The Rest Of Asia Pacific Endoscopic Submucosal Dissection/ESD Market was valued at $14.4 Million in 2025 and projected to reach to $22.4 Million by 2030, representing a compound annual growth rate of 9.3%. The Rest Of Asia Pacific ESD market is positioned for accelerated growth through 2030, driven by escalating gastrointestinal cancer burden and healthcare modernization initiatives.

Rest Of Asia Pacific Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Asia Pacific Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • Rest Of Asia Pacific represents a critical growth corridor for ESD adoption, driven by rising gastrointestinal cancer prevalence, improving healthcare infrastructure, and increasing procedural awareness across emerging economies.
  • The region's 9.3% compound annual growth rate outpaces global benchmarks, reflecting accelerating demand for minimally invasive endoscopic interventions. Rest Of Asia Pacific's market trajectory is underpinned by expanding patient populations, growing physician training initiatives, and rising healthcare expenditure in developing nations.
  • Between 2025 and 2030, Rest Of Asia Pacific is expected to capture significant market share as hospitals and diagnostic centers invest in advanced endoscopic equipment and skilled personnel.
  • The region's competitive dynamics are shaped by both multinational device manufacturers and emerging local players seeking to establish foothold in high-growth markets within Rest Of Asia Pacific..

Key Market Statistics

  • CAGR (2025-2030) 9.3% CAGR
  • Market Size, 2025 ~USD 14.4 Million
  • Forecast, 2030 ~USD 22.4 Million
  • Country Rest Of Asia Pacific

Rest Of Asia Pacific Endoscopic Submucosal Dissection/ESD Market Overview

Market Valuation Growth :

Rest Of Asia Pacific ESD market valued at USD 14.4 million in 2025, expanding to USD 22.4 million by 2030, representing a robust 9.3% CAGR outpacing the global average of 8.4%.

Rising GI Cancer Prevalence :

Increasing incidence of gastrointestinal malignancies across emerging Asia Pacific nations is driving demand for minimally invasive ESD procedures as a preferred treatment modality.

Healthcare Infrastructure Advancement :

Rapid modernization of medical facilities and endoscopy centers in Rest Of Asia Pacific countries is enabling wider adoption of advanced ESD technologies and techniques.

Procedural Awareness Expansion :

Growing physician training programs and patient education initiatives across Rest Of Asia Pacific are accelerating ESD adoption rates and clinical acceptance in the region.

Rest Of Asia Pacific Endoscopic Submucosal Dissection/ESD Market Dynamics

  • Emerging economies in the region are investing heavily in endoscopic capabilities, creating substantial opportunities for ESD adoption.
  • Rising middle-class populations with improved healthcare access and insurance coverage are expanding the patient base eligible for advanced endoscopic interventions. Key growth catalysts include increasing physician expertise through international training collaborations, expanding reimbursement policies, and growing awareness of ESD's advantages over traditional surgical approaches.
  • The region's younger demographic profile and rising healthcare expenditures position Rest Of Asia Pacific as a high-potential market for ESD technology providers and healthcare stakeholders seeking expansion opportunities..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Rest Of Asia Pacific ESD market valued at USD 14.4 million in 2025, expanding to USD 22.4 million by 2030 at 9.3% CAGR
    • Rest Of Asia Pacific growth rate exceeds global average, driven by rising GI cancer incidence and healthcare infrastructure modernization
    • Rest Of Asia Pacific adoption accelerated by physician training programs and increasing procedural awareness in emerging economies
    • Rest Of Asia Pacific competitive landscape includes multinational manufacturers and local players targeting high-growth emerging markets

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    Rest Of Asia Pacific Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : ESD equipment and instrument manufacturers need Rest Of Asia Pacific market intelligence to identify growth opportunities, optimize product portfolios, and establish regional distribution networks.
    • Healthcare Providers & Hospital Networks : Hospital administrators and endoscopy center operators require market data to justify ESD program investments, benchmark performance, and plan capacity expansion in Rest Of Asia Pacific.
    • Investment & Private Equity Firms : Investors evaluating healthcare opportunities in Rest Of Asia Pacific need detailed market sizing and growth projections to assess ESD-related investment potential and ROI forecasts.
    • Pharmaceutical & Biotech Companies : Companies developing ESD-related therapeutics and supportive medications need Rest Of Asia Pacific market data to guide clinical development strategies and commercialization planning.
    • Healthcare Consultants & Analysts : Consulting firms and research organizations require comprehensive Rest Of Asia Pacific ESD market data to support client advisory services, strategic planning, and competitive benchmarking.

    Key Companies in the Rest Of Asia Pacific Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasting : Obtain precise market valuation data specific to Rest Of Asia Pacific (USD 14.4M in 2025, USD 22.4M in 2030) with detailed CAGR analysis to support investment and expansion decisions.
    • Competitive Landscape Intelligence : Identify key players, market share distribution, and competitive strategies tailored to Rest Of Asia Pacific's unique regulatory environment and healthcare dynamics.
    • Growth Driver Analysis : Understand region-specific factors including GI cancer epidemiology, healthcare infrastructure gaps, reimbursement policies, and procedural awareness levels driving ESD market expansion.
    • Country-Level Segmentation : Access granular insights into individual Rest Of Asia Pacific markets, identifying high-growth countries and emerging opportunities for targeted market entry strategies.
    • Strategic Market Entry Planning : Leverage comprehensive Rest Of Asia Pacific data to develop localized go-to-market strategies, partnership opportunities, and investment roadmaps for ESD technology and services.

    Frequently asked questions

    What is the market size of ESD in Rest Of Asia Pacific in 2025?

    Rest Of Asia Pacific's ESD market is valued at USD 14.4 million in 2025.

    What is the projected market size for Rest Of Asia Pacific ESD by 2030?

    Rest Of Asia Pacific's ESD market is forecast to reach USD 22.4 million by 2030.

    What is the CAGR for Rest Of Asia Pacific ESD market?

    Rest Of Asia Pacific's ESD market is expected to grow at a compound annual growth rate of 9.3% from 2025 to 2030.

    What factors are driving growth in Rest Of Asia Pacific ESD market?

    Rest Of Asia Pacific growth is driven by rising gastrointestinal cancer prevalence, improving healthcare infrastructure, physician training initiatives, and increasing procedural awareness in emerging economies.

    Who are the key players in Rest Of Asia Pacific ESD market?

    Rest Of Asia Pacific's competitive landscape includes multinational device manufacturers and emerging local players establishing presence in high-growth emerging markets across the region.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status